Commercial Use License. A license by Xenogen granting rights to any for-profit entity to use the Xenogen Monitoring Technology for commercial drug-development (e.g., compound screening and/or target validation) purposes. It is agreed that the following types of licenses do not constitute a Commercial Use License: (i) an evaluation license granted for the purpose of evaluating Xenogen's technology and/or
Bioware Bioware organisms, such as the September 1998 agreement between the parties executed by Novartis
... Pharmaceuticals Corporation on September 18, 1998, and by Xenogen on September 25, 1998; (ii) a strain development or modification agreement, whereby a third party is licensed to use the Xenogen Monitoring Technology to develop new Bioware Bioware organisms or improve existing Bioware Bioware organisms, without rights to use such Bioware Bioware organisms for its own or contract research drug development purposes; and (iii) a distribution agreement, whereby a third party is granted rights to use the Xenogen Monitoring Technology in connection with the distribution certain Xenogen Bioware Bioware organisms or animals to third parties, without rights to use such Bioware Bioware organisms or animals for its own or contract research drug development purposes.
View More
Commercial Use License. A license by Xenogen granting rights to any for-profit entity to use the Xenogen Monitoring Technology for commercial
drug-development drug- development (e.g., compound screening and/or target validation) purposes. It is agreed that the following types of licenses do not constitute a Commercial Use License: (i) an evaluation license granted for the purpose of evaluating Xenogen's technology and/or
Bioware BiowareTM organisms, such as the September 1998 agreement between the parties executed by
... Novartis Pharmaceuticals Corporation on September 18, 1998, and by Xenogen on September 25, 1998; (ii) a strain development or modification agreement, whereby a third party is licensed to use the Xenogen Monitoring Technology to develop new Bioware BiowareTM organisms or improve existing Bioware BiowareTM organisms, without rights to use such Bioware BiowareTM organisms for its own or contract research drug development purposes; and (iii) a distribution agreement, whereby a third party is granted rights to use the Xenogen Monitoring Technology in connection with the distribution certain Xenogen Bioware BiowareTM organisms or animals to third parties, without rights to use such Bioware BiowareTM organisms or animals for its own or contract research drug development purposes.
View More
Commercial Use License. A license by Xenogen granting rights to any for-profit entity to use the Xenogen Monitoring Technology for commercial
drug-development drug- development (e.g., compound screening and/or target validation) purposes. It is agreed that the following types of licenses do not constitute a Commercial Use License: (i) an evaluation license granted for the purpose of evaluating Xenogen's technology and/or
Bioware Bioware(TM) organisms, such as the September 1998 agreement between the parties executed
... by Novartis Pharmaceuticals Corporation on September 18, 1998, and by Xenogen on September 25, 1998; (ii) a strain development or modification agreement, whereby a third party is licensed to use the Xenogen Monitoring Technology to develop new Bioware Bioware(TM) organisms or improve existing Bioware Bioware(TM) organisms, without rights to use such Bioware Bioware(TM) organisms for its own or contract research drug development purposes; and (iii) a distribution agreement, whereby a third party is granted rights to use the Xenogen Monitoring Technology in connection with the distribution certain Xenogen Bioware Bioware(TM) organisms or animals to third parties, without rights to use such Bioware Bioware(TM) organisms or animals for its own or contract research drug development purposes.
View More